封面
市場調查報告書
商品編碼
1968150

2026-2034年全球藥物溶離度測試服務市場規模、佔有率、趨勢與成長分析報告

Global Pharmaceutical Dissolution Testing Services Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2025 年,藥物溶離度測試服務市場規模將達到 5.0347 億美元,到 2034 年將達到 11.1718 億美元,2026 年至 2034 年的複合年成長率為 9.26%。

隨著製藥公司日益重視確保藥品品質、安全性和合規性,全球藥品溶離度測試服務市場持續成長。溶離度測試在評估藥物活性成分在體內的釋放方面發揮著至關重要的作用。隨著藥物研發活動的增加和監管要求的日益嚴格,對可靠測試服務的需求也穩定上升。

關鍵成長要素包括學名藥生產的擴張、研發活動的活性化以及貫穿整個藥物開發過程的品管需求。透過將檢測服務外包給專業實驗室,製藥公司可以減少時間和營運成本。這種趨勢在中小型製藥公司尤其明顯。

展望未來,檢測設備和自動化技術的進步可望進一步提升服務的效率和準確性。隨著製藥業不斷創新並推出新藥製劑,對先進溶離度測試服務的需求將保持強勁。預計未來幾年,該市場將穩定成長。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球藥物溶離度測試服務市場:依方法分類

  • 市場分析、洞察與預測
  • 體外
  • 體內

第5章:全球藥物溶離度測試服務市場:以劑型分類

  • 市場分析、洞察與預測
  • 膠囊
  • 藥片
  • 其他

第6章:全球藥物溶離度測試服務市場:以溶離度測試設備分類

  • 市場分析、洞察與預測
  • 籃子
  • 其他

第7章 全球藥物溶離度測試服務市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Intertek Group Plc
    • Avivia BV
    • Almac Group
    • Agilent Technologies Inc
    • Catalent Inc
    • Thermo Fisher Scientific Inc
    • Cambrex Corp
    • Charles River Laboratories
    • Boston Analytical
    • Pace Analytical Life Sciences
    • SOTAX
    • AMRI
    • SGS SA
簡介目錄
Product Code: VMR112110342

The Pharmaceutical Dissolution Testing Services Market size is expected to reach USD 1117.18 Million in 2034 from USD 503.47 Million (2025) growing at a CAGR of 9.26% during 2026-2034.

The Global Pharmaceutical Dissolution Testing Services Market is growing as pharmaceutical companies focus on ensuring drug quality, safety, and regulatory compliance. Dissolution testing plays a vital role in evaluating how drugs release active ingredients in the body. With increasing drug development activities and stricter regulatory requirements, demand for reliable testing services is rising steadily.

Key growth drivers include the expansion of generic drug production, rising research activities, and the need for quality control throughout the drug development process. Outsourcing testing services to specialized laboratories helps pharmaceutical companies save time and reduce operational costs. This trend is particularly strong among small and mid-sized pharmaceutical firms.

Looking forward, technological advancements in testing equipment and automation will further enhance service efficiency and accuracy. As the pharmaceutical industry continues to innovate and launch new drug formulations, the need for advanced dissolution testing services will remain strong. The market is expected to grow consistently in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Method

  • In-Vitro
  • In-Vivo

By Dosage Form

  • Capsule
  • Tablets
  • Others

By Dissolution Apparatus

  • Basket
  • Paddle
  • Others

COMPANIES PROFILED

  • Intertek Group Plc, Avivia BV, Almac Group, Agilent Technologies Inc, Catalent Inc, Thermo Fisher Scientific Inc, Cambrex Corp, Charles River Laboratories, Boston Analytical, Pace Analytical Life Sciences, SOTAX, AMRI, SGS SA
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET: BY METHOD 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Method
  • 4.2. In-Vitro Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. In-Vivo Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET: BY DOSAGE FORM 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Dosage Form
  • 5.2. Capsule Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET: BY DISSOLUTION APPARATUS 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Dissolution Apparatus
  • 6.2. Basket Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Paddle Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Method
    • 7.2.2 By Dosage Form
    • 7.2.3 By Dissolution Apparatus
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Method
    • 7.3.2 By Dosage Form
    • 7.3.3 By Dissolution Apparatus
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Method
    • 7.4.2 By Dosage Form
    • 7.4.3 By Dissolution Apparatus
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Method
    • 7.5.2 By Dosage Form
    • 7.5.3 By Dissolution Apparatus
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Method
    • 7.6.2 By Dosage Form
    • 7.6.3 By Dissolution Apparatus
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Intertek Group Plc
    • 9.2.2 Avivia BV
    • 9.2.3 Almac Group
    • 9.2.4 Agilent Technologies Inc
    • 9.2.5 Catalent Inc
    • 9.2.6 Thermo Fisher Scientific Inc
    • 9.2.7 Cambrex Corp
    • 9.2.8 Charles River Laboratories
    • 9.2.9 Boston Analytical
    • 9.2.10 Pace Analytical Life Sciences
    • 9.2.11 SOTAX
    • 9.2.12 AMRI
    • 9.2.13 SGS SA